Aprea Therapeutics Inc
APRE
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.61M
Close$
$2.23
253.9% upside
Current Fair Value
253.9% upsideUndervalued by 253.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.61 Million |
|---|---|
| Enterprise Value | $-41,858,339.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.93 |
| Beta | 1.56 |
| Outstanding Shares | 7,687,961 |
Return
| Return on Equity | -27.92% |
|---|---|
| Return on Assets | -24.85% |
| Return on Invested Capital | -29.04% |
Valuation & Multiples
| P/E Ratio | -0.41 |
|---|---|
| PEG | 2.47 |
| Price to Sales | - |
| Price to Book Ratio | 0.13 |
| Enterprise Value to Revenue | -344.66 |
| Enterprise Value to EBIT | 3.37 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
$253,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 29.19%▲ 3.26% |
|---|---|
| Total Invested | $1.71M▲ 18.39% |
| Investors Holding | 220% |
ESG Score
No data